Clinical Trial

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers

Study acronym: FLACC-Brazil
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 11, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.
Trial Details
NCT Number NCT06965608
Lead Sponsor Hospital Israelita Albert Einstein
Collaborators: International Agency for Research on Cancer
Conditions Cancer, Latin America and the Caribbean Code Against Cancer (LAC Code)
Enrollment 1,200 participants
Start Date 2025-05
Primary Completion 2025-10 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-05-11